Nanosphere Shares Spike 27 Percent on Jefferies Upgrade | GenomeWeb

NEW YORK (GenomeWeb News) – Investment firm Jefferies today upgraded Nanosphere's stock to Buy, driving the firm's shares up 27 percent to $3.20 in Tuesday morning trading.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.